Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Intellectual Bias Policy Takes Wolfe Off Contraceptives Safety Review

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA offered Public Citizen’s Sidney Wolfe a seat at the table for discussion, but no vote. Members need to report relevant information about their conflicts in a timely manner, the agency says.


Related Content

Public Citizen’s Health Group Changes Leadership, But Wolfe Remains On Prowl
Oral Contraceptives Petition Seeking Ban On Third-Generation Products Denied By FDA
Conflict Over Conflicts: FDA Advisory Committee Rules May Be Ripe For Change
Burgess Not Changing Conflict Of Interest Thinking Despite Flap Over Oral Contraceptive AC
Conflict Of Interest Reform: With FDA Undecided, Consumer Groups Give Their Pitch
Non-Contraceptive Use Could Confound Safety Evaluation Of Drospirenone-Containing Products
FDA Advisory Committees Would Get Patient Influence Under Hagan Bill
Prasugrel Intellectual Bias: FDA Makes Changes, Congress Demands Answers
Prasugrel Advisory Committee Highlights FDA’s Continued Credibility Gap
Public Citizen Demands Removal of J&J’s Ortho Evra Patch From Marketplace





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts